Dianosic

Strasbourg, France

Dianosic aims at resolving patient compliance challenges in respiratory care with intranasal, drug-eluting, resorbable scaffolds

$8.2M raised

Sep 2025

Venture - Series Unknown

Top Investors

BpifranceNoshaqCapital Grand EstFinovam GestionAptar Pharma

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Dianosic raised?

Dianosic has raised $8.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.

Who are Dianosic's investors?

Dianosic's investors include Bpifrance, Noshaq, Capital Grand Est, Finovam Gestion, Aptar Pharma.

Where is Dianosic headquartered?

Dianosic is headquartered in Strasbourg, France.

What does Dianosic do?

Dianosic aims at resolving patient compliance challenges in respiratory care with intranasal, drug-eluting, resorbable scaffolds

What stage is Dianosic at?

Dianosic is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 5, 2025.

MLA

"Dianosic — Funding & Investors." VCBacked, September 5, 2025, https://www.vcbacked.co/company/dianosic. Accessed June 4, 2026.

APA

VCBacked. (2025). Dianosic — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/dianosic

Wikipedia (cite web)

{{cite web |title=Dianosic — Funding & Investors |url=https://www.vcbacked.co/company/dianosic |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 5, 2025.